Encompass Health Corporation (NYSE:EHC) reported Q1 EPS of $0.97, $0.05 better than the analyst estimate of $0.92. Revenue for the quarter came in at $1.33 billion versus the consensus estimate of $1.32 billion.
GUIDANCE:
Encompass Health Corporation sees FY2022 EPS of $3.83-$4.19, versus the consensus of $4.10. Encompass Health Corporation sees FY2022 revenue of $5.38-5.5 billion, versus the consensus of $5.45 billion.
For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.